Amanote Research
Register
Sign In
176. AAV-Mediated Gene Therapy in Limb-Girdle Muscular Dystrophy 2I (LGMD2I) Mouse Model
Molecular Therapy
- United States
doi 10.1016/s1525-0016(16)35980-9
Full Text
Open PDF
Abstract
Available in
full text
Categories
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Date
May 1, 2012
Authors
Unknown
Publisher
Elsevier BV
Related search
Plasmid-Mediated Gene Therapy in Mouse Models of Limb Girdle Muscular Dystrophy
Molecular Therapy - Methods and Clinical Development
Molecular Medicine
Genetics
Molecular Biology
Autosomal Recessive Limb-Girdle Muscular Dystrophy Type 2I
Trendelenburg-Like Gait, Instability and Altered Step Patterns in a Mouse Model for Limb Girdle Muscular Dystrophy 2i
PLoS ONE
Multidisciplinary
Limb-Girdle Muscular Dystrophy
Limb Girdle Muscular Dystrophy
Efficient Engraftment of Pluripotent Stem Cell-Derived Myogenic Progenitors in a Novel Immunodeficient Mouse Model of Limb Girdle Muscular Dystrophy 2I
Skeletal Muscle
Orthopedics
Sports Medicine
Cell Biology
Molecular Biology
Myoglobinuria and Muscle Pain Are Common in Patients With Limb-Girdle Muscular Dystrophy 2I
Neurology
Neurology
Limb-Girdle Muscular Dystrophy Due to Emerin Gene Mutations
Archives of Neurology
Autosomal Dominant Limb-Girdle Muscular Dystrophy Type 1A
